Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
DPP9-mediated inflammasome repression protects against checkpoint inhibitor lung toxicity.
Journal: bioRxiv : the preprint server for biology
Published: July 11, 2026
Reverse genetics in humanized mice reveals CARD8-mediated pyroptosis causing pancytopenia in human DPP9 deficiency.
Journal: bioRxiv : the preprint server for biology
Published: July 10, 2026
Retraction: Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.
Journal: The Journal of experimental medicine
Published: June 12, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes.
Journal: Cancer treatment reviews
Published: March 06, 2026
First-Line Integration of Local Ablative Therapy With EGFR Tyrosine Kinase Inhibitors in Advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 01, 2026
Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
Journal: The oncologist
Published: February 16, 2026
A Quarter Century of Transformation: Integrating Molecular Stratification and Immune Modulation Across the Continuum of Non-Small-Cell Lung Cancer.
Journal: Cancer journal (Sudbury, Mass.)
Published: January 30, 2026
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization.
Journal: Nature reviews. Clinical oncology
Published: January 22, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.
Journal: Molecular cancer research : MCR
Published: December 19, 2025
Last Updated: 09/26/2026